Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
Cluster 1 - Health (Single stage - 2027/1). Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to...
€3,000,000 – €11,000,000